Securities Litigation Expert Dr. Jan Jindra Joins The Brattle Group as Principal
Dr. Jindra's expertise spans the valuation of complex securities, insider trading, market manipulation, investment advisor fraud, disclosure violations, initial public offering (IPO) allocations, investor harm, and hedge fund performance, among other topics. He has served as a testifying expert and consultant in both civil and criminal proceedings – including in complex matters involving insider trading, disclosure violations, analysis of trading strategies, enterprise valuation, and valuation of complex securities – for the SEC, the US Department of Justice, and the Federal Trade Commission.
'With his deep industry experience and his wide-ranging securities expertise, Jan will be a tremendous asset to Brattle's clients. Likewise, his collaborative nature and emphasis on developing the next generation of experts make him a wonderful fit for our firm,' said Torben Voetmann, Brattle President & Principal.
At the SEC, in addition to providing expert testimony, Dr. Jindra led teams and actively participated in witness interviews and depositions, settlement negotiations, and the preparation of expert reports. He also oversaw staff development and played a key role in mentoring the next generation of expert witnesses within the agency.
'Brattle is known for its collegial culture and its top-notch team of experts, and I am thrilled to transition back into consulting at such a reputable firm,' said Dr. Jindra. 'I look forward to collaborating with my new colleagues, developing the next generation of experts, and helping clients answer complex economic, finance, and regulatory questions.'
Prior to his tenure at the SEC, Dr. Jindra taught finance courses at The Ohio State University and Menlo College. He also authored numerous peer-reviewed articles in highly reputable finance academic journals. Earlier in his career, he was a Senior Manager at an international economics consultancy.
To learn more about Dr. Jindra, please see his full bio at https://www.brattle.com/experts/jan-jindra/.
ABOUT BRATTLEThe Brattle Group answers complex economic, finance, and regulatory questions for corporations, law firms, and governments around the world. We are distinguished by the clarity of our insights and the credibility of our experts, which include leading international academics and industry specialists. Brattle has 500 talented professionals across four continents. For more information, please visit brattle.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
4 days ago
- Malaysian Reserve
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering
HERZLIYA, Israel and CALGARY, Alberta, July 23, 2025 /PRNewswire/ — Innocan Pharma Corporation ('Innocan' or the 'Company') (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the 'SEC') relating to a proposed public offering of units (each, a 'Unit' and collectively, the 'Units') in the United States. Each Unit will be comprised of one common share of the Company (a 'Common Share') and one common share purchase warrant of the Company (a 'Warrant'). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price and term in the context of the market. Innocan has applied to list its Common Shares and Warrants on the Nasdaq Capital Market under the symbols 'INNP' and 'INNPW', respectively. ThinkEquity is acting as sole book-running manager for the offering. This proposed offering will be made only by means of a prospectus. Upon availability, copies of the preliminary prospectus related to the proposed offering may be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004. The final prospectus will be filed with the SEC and will be available on the SEC's website located at A registration statement relating to this offering has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication to the market shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. Iris Bincovich Innocan Pharma's CEO stated: 'The entire Innocan Pharma team and I are thrilled with having taken this significant step in the process of our listing on the Nasdaq, which opens up exciting new opportunities for us on multiple levels.' About Innocan Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment, Innocan focuses on advanced, targeted online sales, through its BI Sky Global Ltd. subsidiary. For further information, please contact: Iris Bincovich, CEO15162104025++972-54-3012842+442037699377info@ NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. Disclaimer for Forward-Looking Information This press release includes certain statements and information that may constitute 'forward-looking information' within the meaning of applicable Canadian securities laws and/or 'forward-looking statements' within the meaning of applicable United States securities laws (collectively, 'forward-looking statements'). Forward-looking statements relate to future events or future performance and reflect the Company's current estimates, predictions, expectations or beliefs regarding future events and include, without limitation, statements with respect to: statements relating to the public offering of the Company's common shares; the expected timing of the public offering; the registration and listing of the Company's common shares in the United States; the registration statement becoming effective; the SEC's review process; the sizing and pricing of the offering; the means by which the offering will be made; and the Company's business strategies. Often, but not always, forward-looking statements may be identified by the use of words such as 'expects', 'anticipates', 'plans', 'projects', 'estimates', 'assumes', 'intends', 'strategy', 'goals', 'objectives' or variations thereof or stating that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved, or the negative of any of these terms and similar expressions. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements in this press release are based upon, without limitation, the following estimates and assumptions: the Company carrying out its public offering; the Company successfully completing the SEC review process; obtaining requisite regulatory approvals; and general business, economic and market conditions. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Important factors that may cause actual results to vary, include, without limitation, that the Company may not carry out its public offering or complete the SEC review process. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement or forward-looking information, except in accordance with applicable securities laws. Logo – View original content:
Malaysian Reserve
4 days ago
- Malaysian Reserve
Roundhill WeeklyPay™ ETF Suite Surpasses $250 Million in AUM
WeeklyPay™ ETFs are designed to deliver weekly income and uncapped upside on your favorite stocks. NEW YORK, July 23, 2025 /PRNewswire/ — Roundhill Investments, an ETF sponsor focused on innovative financial products, is excited to announce that its WeeklyPay™ ETF suite has exceeded $250 million in assets under management (AUM).¹ Roundhill WeeklyPay™ ETFs are designed to provide investors with weekly distributions while allowing investors to maintain uncapped upside exposure to their favorite stocks, unlike covered call funds. About Roundhill Investments: Founded in 2018, Roundhill Investments is an SEC-registered investment advisor focused on innovative exchange-traded funds. Roundhill's suite of ETFs offers distinct and differentiated exposures across thematic equity, options income, and trading vehicles. Roundhill offers a depth of ETF knowledge and experience, as the team has collectively launched more than 100 ETFs, including several first-to-market products. To learn more about the company, please visit Investors should consider the investment objectives, risks, charges, and expenses carefully before investing. For a prospectus or summary prospectus, if available, with this and other information about the Fund, please call 1-855-561-5728 or visit our website at Read the prospectus or summary prospectus carefully before investing. The performance data quoted represents past performance. Past performance does not guarantee future results. Current performance may be lower or higher than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost. For the most recent standardized and month-end performance, please click the below Fund's U.S. Government Securities Risk. U.S. government securities, such as T-Bills, are subject to interest rate risk but generally do not involve the credit risks associated with investments in other types of debt securities, as such securities are backed by the full faith and credit of the U.S. government. As a result, the yields available from U.S. government securities are generally lower than the yields available from other debt securities. U.S. government securities are guaranteed only as to the timely payment of interest and the payment of principal when held to maturity. Distribution Tax Risk. The Fund currently expects to make distributions on a weekly basis. Such distributions may exceed the Fund's income and gains for the Fund's taxable year. Distributions in excess of the Fund's current and accumulated earnings and profits will be treated as a return of capital. A return of capital distribution generally will not be taxable currently but will reduce the shareholder's cost basis and will result in a higher capital gain or lower capital loss when those Fund Shares on which the distribution was received are sold. Once a Fund shareholder's cost basis is reduced to zero, further distributions will be treated as capital gain if the Fund shareholder holds Fund Shares as capital assets. Additionally, any capital returned through distributions will be distributed after payment of Fund fees and expenses. Because a portion of the Fund's distributions will consist of return of capital, the Fund may not be an appropriate investment for investors who do not want their principal investment in the Fund to decrease over time or who do not wish to receive return of capital in a given period. Interest Rate Risk. Interest rate risk is the risk that the value of the debt securities in the Fund's portfolio will decline because of rising market interest rates. Interest rate risk is generally lower for shorter term debt securities and higher for longer-term debt securities. The Fund may be subject to a greater risk of rising interest rates than would normally be the case due to the current period of historically low rates and the effect of potential government fiscal policy initiatives and resulting market reaction to those initiatives. Inflation Risk. Inflation risk is the risk that the value of assets or income from investments will be less in the future as inflation decreases the value of money. As inflation increases, the present value of the Fund's assets and distributions may decline. This risk is more prevalent with respect to fixed income securities held by the Fund. Active Management Risk. The Fund is actively-managed and its performance reflects investment decisions that the Adviser and/or Sub-Adviser makes for the Fund. Such judgments about the Fund's investments may prove to be incorrect. If the investments selected and the strategies employed by the Fund fail to produce the intended results, the Fund could underperform as compared to other funds with similar investment objectives and/or strategies, or could have negative returns. The Adviser/Sub-Adviser will seek to employ the Fund's investment strategy regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. Non-Diversification Risk. As a 'non-diversified' fund, the Fund may hold a smaller number of portfolio securities than many other funds. To the extent the Fund invests in a relatively small number of issuers, a decline in the market value of a particular security held by the Fund may affect its value more than if it invested in a larger number of issuers. The value of the Fund Shares may be more volatile than the values of shares of more diversified funds. New Fund Risk. The Fund is a recently organized investment company with a limited operating history. Roundhill Financial Inc. serves as the investment advisor. The Funds are distributed by Foreside Fund Services, LLC which is not affiliated with Roundhill Financial Inc., U.S. Bank, or any of their affiliates. ¹ Source: Bloomberg, as of 7/23/2025.
Malaysian Reserve
6 days ago
- Malaysian Reserve
Universal Music Group Confidentially Submits Draft Registration Statement for a Proposed U.S. Public Offering
HILVERSUM, The Netherlands, July 21, 2025 /PRNewswire/ — Universal Music Group N.V. (EURONEXT: UMG) ('UMG' or the 'Company') announced today that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the 'SEC') relating to a proposed public offering in the United States of the Company's ordinary shares held by certain shareholders. UMG will not receive any proceeds from the sale of ordinary shares by the selling shareholders. The number of ordinary shares to be offered and the price range for the proposed offering have not yet been determined. The offering remains subject to the completion of the SEC review process as well as market and other conditions. This press release is being issued pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended ('Securities Act'). This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act. About Universal Music Group At Universal Music Group N.V., we exist to shape culture through the power of artistry. UMG is the world leader in music-based entertainment, with a broad array of businesses engaged in recorded music, music publishing, merchandising and audiovisual content. Featuring the most comprehensive catalogue of recordings and songs across nearly every musical genre, UMG identifies and develops artists and produces and distributes the most critically acclaimed and commercially successful music in the world. Committed to artistry, innovation, and entrepreneurship, UMG fosters the development of services, platforms, and business models in order to broaden artistic and commercial opportunities for our artists and create new experiences for fans. For more information, visit Logo – View original content:
